- -

Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

Mostrar el registro sencillo del ítem

Ficheros en el ítem

[Cerrado]
Nombre: Vivas;E. De la Poza ...
Tamaño: 64.65Kb
Formato: PDF
Descripción: Versión editorial
Solicitar una copia al autor
dc.contributor.author Romero; M. es_ES
dc.contributor.author Usó Talamantes, Ruth es_ES
dc.contributor.author Vivas Consuelo, David José Juan es_ES
dc.contributor.author De la Poza, Elena es_ES
dc.contributor.author Sancho Mestre, C. es_ES
dc.contributor.author Trillo Mata, José Luis es_ES
dc.contributor.author Barrachina Martínez, Isabel es_ES
dc.date.accessioned 2016-04-21T15:38:29Z
dc.date.available 2016-04-21T15:38:29Z
dc.date.issued 2013-11
dc.identifier.issn 1098-3015
dc.identifier.uri http://hdl.handle.net/10251/62810
dc.description.abstract Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) among the top five therapeutic categories of drugs for adults aged 18 and over. Treatment of Diabetes Mellitus (DM) is the main cause of this. Moreover, diabetes is a chronic illness that requires continuous medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Clinical Risk Groups (CRGs) are a tool claimed as valid for diabetes patient management. In this context we use this methodology to conduct a pharmaceutical cost analysis of diabetes in an Eastern Spanish region where the prevalence reaches approximately 8 %. es_ES
dc.language Inglés es_ES
dc.publisher Elsevier es_ES
dc.relation.ispartof Value in Health es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject.classification ECONOMIA, SOCIOLOGIA Y POLITICA AGRARIA es_ES
dc.subject.classification ECONOMIA APLICADA es_ES
dc.subject.classification ECONOMIA FINANCIERA Y CONTABILIDAD es_ES
dc.title Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1016/j.jval.2013.08.2067
dc.rights.accessRights Cerrado es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Economía y Ciencias Sociales - Departament d'Economia i Ciències Socials es_ES
dc.description.bibliographicCitation Romero; M.; Usó Talamantes, R.; Vivas Consuelo, DJJ.; De La Poza, E.; Sancho Mestre, C.; Trillo Mata, JL.; Barrachina Martínez, I. (2013). Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community. Value in Health. 16(7):691-691. https://doi.org/10.1016/j.jval.2013.08.2067 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.1016/j.jval.2013.08.2067 es_ES
dc.description.upvformatpinicio 691 es_ES
dc.description.upvformatpfin 691 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 16 es_ES
dc.description.issue 7 es_ES
dc.relation.senia 252979 es_ES
dc.identifier.eissn 1524-4733


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem